US › Healthcare

Pulse Biosciences Inc (PLSE)

US · Healthcare · Medical Instruments & Supplies

$38.17+1.17%

Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue

$401,000

Revenue YoY

-51.8%

Net profit

$-18.6M

Profit YoY

-10.6%

EPS

$-0.24

EPS estimate

$-0.22

Net margin

-4,633.7%

EPS came in at -0.24 against a street estimate of -0.22 — a miss of 9.7%.

Key statistics

Market cap

$2.43B

Forward P/E

0.0

P/B

36.67

Book value

$0.97

EPS (TTM)

$-1.10

52-week high

$38.29

52-week low

$12.56

50-day MA

$27.59

200-day MA

$20.36

Beta

1.65

Analyst view

with an average price target of $32.33.

Shareholding

Insiders

73.21%

Institutions

12.30%

Largest institutional holders

Fund	Stake
BlackRock Inc	1.94%
Bank of America Corp	1.25%
Vanguard Capital Management, LLC	1.18%
Portolan Capital Management, LLC	1.06%
Geode Capital Management, LLC	0.71%
Massachusetts Financial Services Company	0.67%
State Street Corp	0.66%
Balyasny Asset Management LLC	0.38%

Recent filings & reports

Document	Date
Company announcement · Q3 2026	2026-07-29
Shareholder vote results · Q2 2026	2026-06-12
Company announcement · Q2 2026	2026-06-10
Quarterly report · Q1 2026	2026-05-14
Proxy statement · Q2 2026	2026-05-11
Company announcement · Q2 2026	2026-05-06
Annual report FY2025	2026-02-19
Quarterly report · Q3 2025	2025-11-05

Readable in the app.

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Pulse Biosciences Inc — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc UnitedHealth Group Incorporated Merck & Company Inc Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Novo Nordisk A/S Amgen Inc Abbott Laboratories Gilead Sciences Inc

Data updated 2026-08-05.